BIO US EQUITY Health Care Health Care CIK: 12208

BIO-RAD LABORATORIES, INC. (BIO) Quant Factor Diagnostic & Fair Value Model

BIO-RAD LABORATORIES, INC. (Ticker: BIO) is listed in the Health Care sector (Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$369.95

+1.77% Latest Close (2026-10-23)

Market Cap: $14.97M

P/E Ratio: 44.3

Momentum Strength 3M / 12M

+16.92%

1M: -4.54% 12M: 0.00%

Quality (ROE) Point-in-Time

Trailing Return on Equity

Technical Trend RSI 14

41.8

SMA50: $373.00 SMA200: $343.75

Valuation Multiplier Trailing

44.3

Premium Multiple (> 30x P/E)

📊 Valuation & Multi-Factor Diagnostic

Premium Multiple (> 30x P/E)

BIO trades at 44.3x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.

Compare in Screener

⚡ Benchmark Factor Strategy

S&P 500 Momentum Alpha Strategy

This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

Strategy Marketplace Open Strategy →

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线多头 (MA20/50) Piotroski F-Score: 5/9 (Moderate Financial Health)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 12208 · 10-K 年报 / 10-Q 季报

Form	Period End	Filing Timestamp (Point-in-Time)	Revenue	Net Income	Operating CF	EPS (Diluted)
No point-in-time filings synced yet. Automated batch scheduler will align CIK: 12208

💡 Methodology & Frequently Asked Questions

Key reference details regarding BIO-RAD LABORATORIES, INC. (BIO) valuation multiples, momentum factors, and point-in-time filing conventions.

How should BIO's current valuation multiple be interpreted? ↓

BIO trades at a trailing P/E of 44.3x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.

What are BIO's key momentum and technical factor indicators? ↓

As of the latest close, BIO shows a 1-month return of -4.54%, 3-month return of +16.92%, and 12-month return of 0.00%, with a 14-day RSI of 41.8. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.

What is Point-in-Time (PIT) financial data and why does it matter for BIO? ↓

Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.

How can BIO be incorporated into systematic factor models? ↓

BIO can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.